Cancer and Aging: Two Tightly Interconnected Biological Processes.
aging
biomarkers
cancer
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
19 Mar 2021
19 Mar 2021
Historique:
received:
09
02
2021
revised:
15
03
2021
accepted:
17
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
4
4
2021
Statut:
epublish
Résumé
Age is one of the main risk factors of cancer; several biological changes linked with the aging process can explain this. As our population is progressively aging, the proportion of older patients with cancer is increasing significantly. Due to the heterogeneity of general health and functional status amongst older persons, treatment of cancer is a major challenge in this vulnerable population. Older patients often experience more side effects of anticancer treatments. Over-treatment should be avoided to ensure an optimal quality of life. On the other hand, under-treatment due to fear of toxicity is a frequent problem and can lead to an increased risk of relapse and worse survival. There is a delicate balance between benefits of therapy and risk of toxicity. Robust biomarkers that reflect the body's biological age may aid in outlining optimal individual treatment regimens for older patients with cancer. In particular, the impact of age on systemic immunity and the tumor immune infiltrate should be considered, given the expanding role of immunotherapy in cancer treatment. In this review, we summarize current knowledge concerning the mechanistic connections between aging and cancer, as well as aging biomarkers that could be helpful in the field of geriatric oncology.
Identifiants
pubmed: 33808654
pii: cancers13061400
doi: 10.3390/cancers13061400
pmc: PMC8003441
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13987-92
pubmed: 18765803
Subcell Biochem. 2018;90:49-97
pubmed: 30779006
Psychooncology. 2020 Aug;29(8):1347-1354
pubmed: 32567082
J Gerontol A Biol Sci Med Sci. 2014 Jun;69 Suppl 1:S4-9
pubmed: 24833586
Exp Gerontol. 1999 Dec;34(8):959-70
pubmed: 10673149
Am J Epidemiol. 2017 Jun 15;185(12):1317-1326
pubmed: 28459963
Aging (Albany NY). 2015 May;7(5):319-33
pubmed: 25989735
J Vis Exp. 2017 May 1;(123):
pubmed: 28518126
Clin Interv Aging. 2018 Apr 26;13:757-772
pubmed: 29731617
Nat Rev Cancer. 2012 Oct;12(10):709-20
pubmed: 22952011
Cancer Commun (Lond). 2020 Apr;40(4):135-153
pubmed: 32301585
Annu Rev Pathol. 2010;5:99-118
pubmed: 20078217
Med Hypotheses. 2006;67(2):212-5
pubmed: 16546325
Aging Cell. 2009 Aug;8(4):439-48
pubmed: 19485966
Clin Exp Immunol. 2005 Jun;140(3):540-6
pubmed: 15932517
Lancet Healthy Longev. 2020 Oct;1(1):e43-e47
pubmed: 36094187
Cell. 2013 Jun 6;153(6):1194-217
pubmed: 23746838
Cancer. 1997 Oct 1;80(7):1273-83
pubmed: 9317180
Arch Immunol Ther Exp (Warsz). 2016 Apr;64(2):111-26
pubmed: 26658771
Nature. 2007 Aug 16;448(7155):767-74
pubmed: 17700693
CA Cancer J Clin. 2017 Sep;67(5):362-377
pubmed: 28731537
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
J Geriatr Oncol. 2014 Apr;5(2):204-18
pubmed: 24495695
Breast. 2014 Feb;23(1):81-7
pubmed: 24314824
Mech Ageing Dev. 2013 Mar;134(3-4):139-57
pubmed: 23428415
Oncogene. 2008 Oct 6;27(45):5959-74
pubmed: 18836476
Trans Am Clin Climatol Assoc. 2006;117:147-55; discussion 155-6
pubmed: 18528470
J Gerontol A Biol Sci Med Sci. 2004 Mar;59(3):242-8
pubmed: 15031308
Nature. 2011 Nov 02;479(7372):232-6
pubmed: 22048312
Clin Cancer Res. 2018 Nov 1;24(21):5347-5356
pubmed: 29898988
J Geriatr Oncol. 2017 May;8(3):229-235
pubmed: 28223073
F1000Res. 2017 Jun 9;6:860
pubmed: 28663789
Drugs Aging. 2019 Oct;36(10):927-938
pubmed: 31317421
Gut Pathog. 2018 Feb 09;10:4
pubmed: 29449892
Nat Med. 2019 Mar;25(3):377-388
pubmed: 30842679
Immun Ageing. 2010 Aug 17;7:9
pubmed: 20716329
CA Cancer J Clin. 2016 Jul;66(4):337-50
pubmed: 26891458
Trends Cancer. 2019 Aug;5(8):475-494
pubmed: 31421905
N Engl J Med. 2006 Sep 7;355(10):1037-46
pubmed: 16957149
Cancer Causes Control. 2016 Nov;27(11):1361-1370
pubmed: 27734240
Cancers (Basel). 2021 Jan 27;13(3):
pubmed: 33513872
Neuromolecular Med. 2011 Mar;13(1):37-43
pubmed: 20632131
PLoS One. 2014 Oct 21;9(10):e110644
pubmed: 25333486
Semin Immunol. 2012 Oct;24(5):331-41
pubmed: 22560929
PLoS One. 2015 Mar 18;10(3):e0117954
pubmed: 25785999
Curr Biol. 2016 Jun 6;26(11):1480-5
pubmed: 27185560
Clin Transl Immunology. 2020 Oct 03;9(10):e1184
pubmed: 33024560
Genome Biol. 2014 Feb 03;15(2):R24
pubmed: 24490752
Immunology. 2015 Jan;144(1):1-10
pubmed: 25093579
Front Endocrinol (Lausanne). 2019 Feb 01;10:27
pubmed: 30774624
Nat Commun. 2015 Oct 22;6:8570
pubmed: 26490707
Cell. 1999 May 14;97(4):527-38
pubmed: 10338216
Front Immunol. 2018 Jan 10;8:1960
pubmed: 29375577
Nature. 2020 Jul;583(7814):127-132
pubmed: 32555459
Curr Mol Med. 2005 Mar;5(2):187-96
pubmed: 15974872
Immun Ageing. 2008 Jul 25;5:6
pubmed: 18657274
Mod Pathol. 2015 Jun;28(6):766-77
pubmed: 25720324
Lancet Oncol. 2012 Apr;13(4):e148-60
pubmed: 22469125
CA Cancer J Clin. 2019 Nov;69(6):452-467
pubmed: 31390062
Best Pract Res Clin Endocrinol Metab. 2017 Feb;31(1):113-125
pubmed: 28477727
J Cell Biol. 2018 Jan 2;217(1):65-77
pubmed: 29114066
Exp Gerontol. 2004 Nov-Dec;39(11-12):1751-9
pubmed: 15582292
Cancer Res. 2019 Aug 1;79(15):3806-3814
pubmed: 31300477
EMBO Rep. 2011 Jul 01;12(7):647-56
pubmed: 21660058
Front Genet. 2013 Jun 26;4:121
pubmed: 23805154
Eur J Cancer. 2012 Apr;48(6):805-12
pubmed: 21741826
Hum Genet. 2013 Dec;132(12):1323-38
pubmed: 23925498
Lancet. 2003 Feb 1;361(9355):393-5
pubmed: 12573379
Annu Rev Genet. 2019 Dec 3;53:239-261
pubmed: 31487470
Subcell Biochem. 2019;91:21-43
pubmed: 30888648
Aging (Albany NY). 2015 Nov;7(11):956-63
pubmed: 26568155
Genome Biol. 2015 Jan 30;16:25
pubmed: 25633388
Mech Ageing Dev. 2015 Nov;151:60-70
pubmed: 25708826
Nature. 2012 Aug 9;488(7410):178-84
pubmed: 22797518
JAMA. 1998 Apr 15;279(15):1187-93
pubmed: 9555758
Nat Rev Endocrinol. 2013 Jun;9(6):366-376
pubmed: 23591370
J Frailty Aging. 2018;7(2):100-103
pubmed: 29741193
Antioxid Redox Signal. 2007 Jan;9(1):143-50
pubmed: 17115893
Arch Intern Med. 2002 Jan 28;162(2):201-8
pubmed: 11802754
Annu Rev Physiol. 2013;75:685-705
pubmed: 23140366
Cancer Lett. 2014 Apr 10;345(2):196-202
pubmed: 23981572
Physiology (Bethesda). 2008 Apr;23:64-74
pubmed: 18400689
EMBO Rep. 2006 May;7(5):546-52
pubmed: 16582880
Nature. 2002 Jan 3;415(6867):45-53
pubmed: 11780111
Aging Cell. 2014 Aug;13(4):769-71
pubmed: 24618355
Nature. 2019 Jul;571(7764):183-192
pubmed: 31292558
Alzheimer Dis Assoc Disord. 2015 Apr-Jun;29(2):177-82
pubmed: 25710132
Biogerontology. 2017 Aug;18(4):717-721
pubmed: 28220304
Mutat Res. 2011 Jun 3;711(1-2):193-201
pubmed: 21216256
J Clin Oncol. 2011 Sep 1;29(25):3457-65
pubmed: 21810685
J Clin Endocrinol Metab. 2010 Oct;95(10):4616-24
pubmed: 20610588
Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10513-8
pubmed: 18663219
Nat Rev Cancer. 2018 Jul;18(7):433-441
pubmed: 29622806
J Clin Invest. 2017 Feb 1;127(2):437-446
pubmed: 28145903
J Natl Cancer Inst. 2001 Oct 17;93(20):1557-62
pubmed: 11604479
Oncology (Williston Park). 2006 Feb;20(2):135-43; discussion 144, 146, 151-2
pubmed: 16562648
Immun Ageing. 2006 Nov 29;3:10
pubmed: 17134511
J Clin Oncol. 2004 Jun 15;22(12):2388-94
pubmed: 15197200
Exp Gerontol. 2018 May;105:4-9
pubmed: 29111233
Trends Biochem Sci. 2021 Jan;46(1):80-82
pubmed: 33097382
Aging Dis. 2017 Oct 1;8(5):628-642
pubmed: 28966806
Aging Cell. 2011 Aug;10(4):686-98
pubmed: 21418511
Brain Behav Immun. 2013 Mar;30 Suppl:S163-70
pubmed: 22884416
Nature. 2001 Sep 6;413(6851):86-91
pubmed: 11544531
FASEB J. 2003 Jul;17(10):1195-214
pubmed: 12832285